Ascending Single-Dose and Multiple-Dose Study to Evaluate RJ4287 in Healthy Subjects

NCT05921006 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Safety

Interventions

DRUG: RJ4287
DRUG: Placebo

Sponsor

Nanjing Ruijie Pharma Co., Ltd.